Loading people...
Owen Smith is Partner at 4BIO Capital, based in London, United Kingdom.
Owen Smith is a Partner at 4BIO Capital, an international venture capital firm based in London, UK. Since joining the firm in 2018, he has leveraged over a decade of early-stage biotech investing experience to support portfolio startups through two to three successive funding rounds. He currently sits on the boards of portfolio companies including EntactBio and SparingVision. Prior to his current venture capital role, Smith began his investment career at Arix Bioscience plc, following initial financial assurance and advisory positions where he qualified and worked as a chartered accountant. He holds an MSc in Experimental and Translational Therapeutics from the University of Oxford. His current investment focus centers on seeding and scaling early-stage biotech startups developing advanced curative treatments, specifically targeting cell therapy, gene therapy, and RNA medicines across the United Kingdom, Europe, and the United States.
